DE612513T1 - Äusserliche Hautpflegemittel. - Google Patents

Äusserliche Hautpflegemittel.

Info

Publication number
DE612513T1
DE612513T1 DE0612513T DE94108140T DE612513T1 DE 612513 T1 DE612513 T1 DE 612513T1 DE 0612513 T DE0612513 T DE 0612513T DE 94108140 T DE94108140 T DE 94108140T DE 612513 T1 DE612513 T1 DE 612513T1
Authority
DE
Germany
Prior art keywords
external skin
skin treatment
preparation
polyoxyethylene
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0612513T
Other languages
English (en)
Inventor
Kenzo Ito
Yoshimaru Kumano
Fumiaki Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of DE612513T1 publication Critical patent/DE612513T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Claims (6)

108 140.8 SHISEIDO COMPANY, LIMITED Patentansprüche
1. Zubereitung zur externen Blutbehandlung, umfassend Erythrit, hydriertes Lezithin und ein Polyoxyethylen-Addukt eines Cholesterinderivats.
2. Zubereitung zur externen Hautbehandlung nach Anspruch 1, wobei an 1 Mol des Cholesterinderivats des Cholesterinderivat-Polyoxyethylenaddukts 5 bis 70 Mole PoIyoxyethylen addiert sind.
3. Zubereitung zur externen Hautbehandlung nach Anspruch 1, wobei es sich bei dem Cholesterinderivat-Polyoxyethylen-Addukt um Polyoxyethylen(30)-Cholesterinether mit 30 Molen an addiertem Polyoxyethylen pro 1 Mol Cholesterinether handelt.
4. Zubereitung zur externen Hautbehandlung nach Anspruch 1, wobei der Erythritgehalt, bezogen auf das Gewicht der Zubereitung für die externe Hautbehandlung, 0,1 bis 30 Gew.-% beträgt.
5. Zubereitung zur externen Hautbehandlung nach Anspruch 1, wobei der Gehalt an hydriertem Lezithin, bezogen auf das Gewicht der Zubereitung zur externen Hautbehandlung, 0,0001 bis 1 Gew.-% beträgt.
6. Zubereitung zur externen Hautbehandlung nach Anspruch 1, wobei der Gehalt an dem Cholesterinderivat-Polyoxyethylen-Addukt, bezogen auf das Gewicht der Zubereitung für die externe Hautbehandlung, 0,0001 bis 1 Gew.-% beträgt.
DE0612513T 1994-05-02 1994-05-26 Äusserliche Hautpflegemittel. Pending DE612513T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP09350094A JP3344822B2 (ja) 1994-05-02 1994-05-02 皮膚外用剤

Publications (1)

Publication Number Publication Date
DE612513T1 true DE612513T1 (de) 1995-03-16

Family

ID=14084075

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0612513T Pending DE612513T1 (de) 1994-05-02 1994-05-26 Äusserliche Hautpflegemittel.
DE69423805T Expired - Lifetime DE69423805T2 (de) 1994-05-02 1994-05-26 Äusserliche Hautpflegemittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69423805T Expired - Lifetime DE69423805T2 (de) 1994-05-02 1994-05-26 Äusserliche Hautpflegemittel

Country Status (5)

Country Link
US (1) US5753242A (de)
EP (1) EP0612513B1 (de)
JP (1) JP3344822B2 (de)
DE (2) DE612513T1 (de)
ES (1) ES2144017T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19537027A1 (de) 1995-10-05 1997-04-10 Beiersdorf Ag Hautpflegemittel für alte Haut
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
EP0943324A3 (de) * 1998-03-17 2002-01-02 Shiseido Company, Ltd. Äusserliche Hautbehandlungszusammensetzung
JP3557544B2 (ja) * 1998-05-15 2004-08-25 株式会社コーセー 角質柔軟化粧料
TWI266639B (en) * 1998-11-13 2006-11-21 Ajinomoto Kk Weak acid skin cleanser
CN1176724C (zh) * 1999-07-13 2004-11-24 安得勋 婴儿用卫生材料中含有的中药组合物
JP2002265347A (ja) * 2001-03-13 2002-09-18 Shiseido Co Ltd コーニファイドエンベロープの成熟を促す化粧料
KR100465976B1 (ko) * 2002-01-05 2005-01-13 주식회사 태평양 나노유화기술에 의해 진세노사이드 ｆ1을 함유하는 미세 유화 입자 및 이를 사용한 피부 외용제 조성물
US20040213821A1 (en) * 2003-01-31 2004-10-28 The Procter & Gamble Company Skin care composition comprising first and second emulsions
US20050238598A1 (en) * 2004-04-07 2005-10-27 Lionnel Aubert Antiperspirant compositions and method comprising wax microparticles
JP5101808B2 (ja) * 2004-09-16 2012-12-19 株式会社コーセー 水中油型液状組成物
US7258079B2 (en) * 2005-10-17 2007-08-21 Ken Foster Apparatus and method for waterproofing game birds
DE102006035040A1 (de) * 2006-07-28 2008-01-31 Beiersdorf Ag Wirkstoffkombinationen aus Ascorbylverbindung und hydriertem Lecithin
FR2927801B1 (fr) * 2008-02-22 2010-03-05 Sederma Sa Composition cosmetique hydratante comprenant une combinaison d'homarine et d'erythritol
EP2100582B1 (de) * 2008-03-10 2012-11-28 The Procter & Gamble Company Kosmetische Zusammensetzung
KR101889327B1 (ko) * 2014-12-31 2018-09-20 (주)아모레퍼시픽 다양한 유화 입자 사이즈를 함유하는 혼성 유화 조성물 및 그 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58121209A (ja) * 1982-01-11 1983-07-19 Eisai Co Ltd 乳化型外用組成物
IT1193614B (it) * 1983-01-24 1988-07-21 Crinos Industria Farmaco Preparato per l'igiene e la pulizia della pelle del cuoio capelluto e dei capelli
WO1988000572A1 (en) * 1986-07-24 1988-01-28 Shiseido Company Ltd. Spherical clay mineral powder, process for its production, and composition containing same
DE68917544T2 (de) * 1988-06-20 1994-12-15 Shiseido Co Ltd Durchsichtiges Präparat.
WO1990001323A1 (en) * 1988-08-12 1990-02-22 Bernstein Joel E Method and composition for treating and preventing dry skin disorders
JP2866114B2 (ja) * 1989-09-20 1999-03-08 株式会社資生堂 化粧料
US5221796A (en) * 1991-02-12 1993-06-22 Fuji Photo Film Co., Ltd. Glycerol derivatives
US5310555A (en) * 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition

Also Published As

Publication number Publication date
EP0612513A2 (de) 1994-08-31
ES2144017T3 (es) 2000-06-01
US5753242A (en) 1998-05-19
JPH07300408A (ja) 1995-11-14
DE69423805T2 (de) 2001-01-25
EP0612513A3 (en) 1995-12-06
EP0612513B1 (de) 2000-04-05
JP3344822B2 (ja) 2002-11-18
DE69423805D1 (de) 2000-05-11

Similar Documents

Publication Publication Date Title
DE612513T1 (de) Äusserliche Hautpflegemittel.
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
ATE72238T1 (de) Imidazoliumsalze, zwischenprodukte fuer ihre herstellung sowie ihre verwendung.
ES2058096T3 (es) Producto cosmetico que contiene derivados n-hidroxi-propil-isopropileter de la quitosana.
DE69506686D1 (de) Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase
ZA932388B (en) Derivatives of phenylacetic acid their preparation and their use as pesticides
EP0294695A3 (de) Polysauerstoffhaltige Labdan-Derivate, Verfahren zu deren Herstellung und deren Herstellung als Arzneimittel
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
BR9708388A (pt) Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação.
AU1829195A (en) Energy formulation
DE59008921D1 (de) Dibenzo(1,5)dioxocin-5-one-Derivate, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung.
IL58587A (en) Esters of 1,1,2-triphenylalkene derivatives,their preparation and pharmaceutical compositions comprising them
IL89325A0 (en) Optically active rhodium complexes of 3,4-bis(diarylphosphino)pyrrolidines and their use for the preparation of phosphinothricin by asymmetric hydrogenation
AU1645897A (en) Benzopyran derivative and use of said benzopyran derivative for treating heart disease
EP0778027A3 (de) Verwendung von Kieselerde zur Herstellung von Arzneimitteln
FR2365557A1 (fr) Nouveaux perhydro-indolinols, leur preparation et leur application comme medicaments
BR9813098A (pt) Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào
ES2019037A6 (es) Procedimiento para la preparacion de una composicion topica de utilidad en el tratamiento de manchas de la piel.
Evans Sacrificed to an archaic training system.
Roberts Scientists' new year: From dismal to delightful.
CS9000583A2 (en) Catheter for heart's electrophysiological examination
Smith Call for a Health Services Inspectorate.
ES2140922T3 (es) Benzoilguanidinas orto-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
Williams et al. Health policies in the 1992 general election.
Weissenstein VA considers options to reduce personnel.